Characteristics of breast metastases from non-breast solid tumors in 22�patients from a southern Chinese population

Abstract

Breast metastases from solid non-breast tumor types are rare; however, they should be always considered in the differential diagnosis of a breast lesion owing to the associated poor patient prognosis and the requirement of different therapeutic strategies compared with those used to treat primary breast cancer. The aim of the current study was to summarize the characteristics of metastases to the breast in a southern Chinese population. The medical records and pathological sections of 22 patients with pathologically confirmed extra-mammary metastases to the breast that presented to Sun Yat-sen University Cancer Center between January 2000 and December 2015 were retrospectively reviewed. The median age of onset for breast metastasis was 43 years (range, 10–62 years) and 19 (86.4%) patients had a known history of a primary tumor. The mean interval from diagnosis of the primary tumor to breast metastasis was 16.5 months (range, 6–56 months). A unilateral (45.5% left, 36.4% right), upper outer quadrant (15/22, 68.2%) lesion of the breast was most frequently initially detected by self-checking (63.6%). The most common origin of the primary tumor was the lung (22.7%). Nasopharyngeal carcinoma accounted for a high proportion of the metastases (18.2%). The median duration of survival from the time of diagnosis of a breast metastasis was 14 months (range, 2–74 months). A total of 10 patients (45.5%) succumbed to the disease. The results also indicated that overall survival in patients that underwent surgery was improved compared with patients who did not undergo surgery. The results of the present study demonstrated that clinical history, imaging findings, pathology from the primary tumor and immunostaining were required in combination to establish an accurate diagnosis. Further investigation into the improvement of the prognosis of patients with metastases to the breast following surgery is required.

99mTc-Radiolabeled Silica Nanocarriers for Targeted Detection and Treatment of HER2-Positive Breast Cancer

“…The role of Filamin A as inhibitor of tumor progression, through regulating BRCA1 expression in human breast cancer, has been recently clarified. 43 , 44 Exclusively DOX-SiNPs administration reduced the expression of Sarco/Endoplasmic Reticulum ATPase 1 protein (ATP2A1), named SERCA, this protein plays an important role in the regulation of intracellular calcium levels. Inhibitors of SERCA increase cytosolic calcium levels, triggering various pathways with a resulting promotion of cell death.…”

An uncommon breast metastasis of mediastinal neuroblastoma within a child: A case report

“…Breast metastases from extramammary neoplasms are rare, accounting for 0.3% to 2% of all malignancies in the breast 1 . Primary sources arise often from lymphoma, melanoma, lung, ovary, gastrointestinal tract in adults, and rhabdomyosarcoma in children 2,3 .…”

<p>Metastases to the Breast from Extramammary Nonhematological Malignancies: Case Series</p>

“…2,3 In addition to metastasis of contralateral mammary cancer, the most common primary tumors with breast metastases are hematologic malignancies, including leukemia and lymphoma. 2,[4][5][6] Breast metastases have also been reported in primary cancers such as melanoma, lung cancer, ovarian cancer, gastric cancer and neuroendocrine cancer. [7][8][9] To avoid unnecessary and potentially harmful treatments, accurate diagnosis of secondary breast carcinoma is very important.…”